Ichiro Suzuki, whose outstanding play in Japanese baseball led him to international stardom in the major leagues, was ...

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

MLB analyst Harold Reynolds said there is a 0 percent chance free agent pitcher Roki Sasaki will not sign with the Los ...

Joint bid for U.S. Steel assets would have Cleveland-Cliffs acquiring blast furnace mills and Nucor taking over Big River ...

Hoping to become a two-way player in Major League Baseball just like Shohei Ohtani, 18-year-old Shotaro Morii made the rare decision to bypass Japanese professional baseball entirely and agreed ...

Texas QB Quinn Ewers declares for NFL draft as program ushers in Arch Manning era Zelenskyy visits Poland amid breakthrough ...

The Nationals signed outfielder/first baseman Franchy Cordero to a minor league contract, according to Aram Leighton of Just ...

Hoping to become a two-way player in MLB just like Shohei Ohtani, 18-year-old Shotaro Morii made the rare decision to bypass ...

The Athletics made waves to kick off the 2025 international signing period, inking 18-year-old two-way player Shotaro Morii ...

A steel manufacturing plant is visible from the Monongahela River Locks and Dam 2 in Braddock, Pa., on April 25, 2023.

Undervalued biotech company Regenxbio Inc. shows promise with cutting-edge gene therapy technology for AMD and MPS II. Click ...